文献速递肾移植

载脂蛋白L1基因检测与咨询未降低活体供肾者捐献意愿:一项混合2型非随机对照试验

Apolipoprotein L1 Genetic Testing and Counseling Does Not Reduce Living Kidney Donors' Willingness to Donate : A Hybrid Type 2 Nonrandomized Controlled Trial.
PubMed 文献 · Clin J Am Soc Nephrol · 2026-04-20

该研究在280名非洲裔潜在活体供肾者中评估APOL1基因检测与咨询项目的效果。干预组接受聊天机器人信息、文化适配咨询和APOL1基因检测,对照组接受常规护理。结果显示干预未显著降低捐献决策冲突、未提高决策准备度或捐献意愿,但证实了将检测整合入常规评估的可行性。

要点

  • APOL1基因检测与咨询未降低非洲裔潜在供肾者的捐献意愿。
  • 干预未改善决策冲突、决策准备度或捐献准备度。
  • 该干预可整合入常规活体供肾者临床评估流程。

核心结论

  • APOL1检测与咨询项目对潜在供肾者的捐献意愿无影响,且未降低决策冲突或提高准备度。
  • 该干预整合入常规供肾者临床评估是可行的。

研究设计与样本

  • 前瞻性、非随机、前后对照、两中心混合2型效果-实施研究,纳入280名非洲裔潜在活体供肾者(对照组75人,干预组205人,参与率71.07%)。
  • 干预包括聊天机器人提供APOL1信息、文化胜任咨询和APOL1基因检测;对照组接受常规护理。
  • 采用线性混合效应模型分析纵向实施结局,多元回归分析横断面结局。

主要发现

  • 决策冲突β(95%CI)为-1.05(-4.13至2.03),P=0.50。
  • 决策准备β(95%CI)为-7.02(-18.83至4.78),P=0.24。
  • 捐献准备度β(95%CI)为0.04(-0.48至0.56),P=0.89。
  • 捐献意愿β(95%CI)为0.18(-0.29至0.66),P=0.45。
  • 知情同意满意度中「做出决定所需信息量」维度干预组显著更低,β(95%CI)为-0.34(-0.65至-0.02),P=0.04。

临床怎么用

  • APOL1基因检测与咨询可安全整合入非洲裔活体供肾者的常规临床评估,不担忧降低捐献意愿。
  • 需关注干预可能降低供肾者对信息量的满意度,优化信息提供方式。

局限性

  • 非随机设计,可能存在选择偏倚。
  • 仅纳入非洲裔潜在供肾者,外推性受限。
  • 参与率71.07%,未参与者的特征未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Apolipoprotein L1 genetic testing did not reduce potential living donors' willingness to donate, supporting integration of testing into practice. The Apolipoprotein L1 Testing and Counseling Program did not reduce potential living donors' decisional conflict or increase preparedness to donate. The trial demonstrated the feasibility of integrating apolipoprotein L1 genetic testing and counseling into routine living donor clinical evaluation. BACKGROUND: Living donors of African ancestry have the highest risk of postdonation kidney disease. Apolipoprotein L1 ( APOL1 ) risk variants may contribute to this risk. This study evaluated the effectiveness and implementation of our culturally appropriate APOL1 Testing and Counseling Program to reduce potential donors' decisional conflict for donation. METHODS: This prospective, nonrandomized, pre-post two-site hybrid type 2 effectiveness-implementation study evaluated the effect of the intervention on decisional conflict about donation, preparedness for decision making about donation and for donation, willingness to donate, and satisfaction with informed consent among potential donors of African ancestry undergoing evaluation. The intervention involved donors: using a chatbot providing APOL1 information, receiving culturally competent counseling, and APOL1 genetic testing. Control arm received routine care. We used the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework to longitudinally evaluate implementation outcomes assessed through validated surveys with donors and electronic health record review using linear mixed effects models. Cross-sectional outcomes were assessed using multiple regression models. RESULTS: We enrolled 280 potential donors (75 control arm, 205 intervention arm; 71.07% participation rate). More were female (59%) and had a mean age of 40.2 years (SD, 12.8). No significant differences emerged in most primary and secondary outcomes between the intervention and control groups (decisional conflict β [95% confidence interval (CI)], -1.05 [-4.13 to 2.03]; P = 0.50), preparation for decision making ( β [95% CI], -7.02 [-18.83 to 4.78]; P = 0.24), preparedness to donate ( β [95% CI], 0.04 [-0.48 to 0.56]; P = 0.89), willingness to donate ( β [95% CI], 0.18 [-0.29 to 0.66]; P = 0.45). The right amount of information to make a decision domain for satisfaction with informed consent was significantly lower in the intervention arm ( β [95% CI], -0.34 [-0.65 to -0.02]; P = 0.04). CONCLUSIONS: Our APOL1 Testing and Counseling Program had no effect on potential donors' willingness to donate regardless of undergoing APOL1 testing, demonstrating the feasibility of its integration into routine donor clinical evaluation. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: NCT04910867 .

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Gordon EJ, Gacki-Smith J, Smith JD, et al. Apolipoprotein L1 Genetic Testing and Counseling Does Not Reduce Living Kidney Donors' Willingness to Donate : A Hybrid Type 2 Nonrandomized Controlled Trial. Clin J Am Soc Nephrol. 2026. PMID: 42008800. doi:10.2215/CJN.0000001064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。